Aldosterone Antagonist [EPC]

Aldosterone Antagonist [EPC] was reported 156008 times

Drugs of the Aldosterone Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EJECTION FRACTION 232 0.3993
1 SENSITISATION 257 0.3386
2 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 350 0.2491
3 CARDIAC FAILURE CHRONIC 855 0.2004
4 JUGULAR VEIN DISTENSION 109 0.1922
5 DEVICE MAINTENANCE ISSUE 109 0.1854
6 POLYCYSTIC OVARIES 283 0.1823
7 HYPERKALAEMIA 5490 0.1564
8 CARDIOACTIVE DRUG LEVEL INCREASED 205 0.1559
9 BRASH SYNDROME 210 0.1496
10 DYSPNOEA PAROXYSMAL NOCTURNAL 106 0.1454
11 SPUTUM CULTURE POSITIVE 114 0.1404
12 EJECTION FRACTION ABNORMAL 169 0.1378
13 ORTHOPNOEA 433 0.1358
14 CARDIAC AMYLOIDOSIS 143 0.1299
15 BRAIN NATRIURETIC PEPTIDE INCREASED 386 0.1251
16 RIGHT VENTRICULAR FAILURE 845 0.1205
17 ISCHAEMIC CARDIOMYOPATHY 356 0.1160
18 HEPATIC ENCEPHALOPATHY 1063 0.1138
19 HEPATORENAL SYNDROME 177 0.1048
20 LEFT ATRIAL DILATATION 126 0.0987
21 PULMONARY ARTERIAL PRESSURE INCREASED 158 0.0969
22 ACUTE PRERENAL FAILURE 112 0.0967
23 CONGESTIVE CARDIOMYOPATHY 399 0.0956
24 ATRIAL TACHYCARDIA 194 0.0923
25 PRODUCT MONITORING ERROR 132 0.0913
26 OESOPHAGEAL VARICES HAEMORRHAGE 196 0.0902
27 INFUSION SITE DISCHARGE 155 0.0883
28 CARDIAC FAILURE ACUTE 566 0.0849
29 OBSTRUCTIVE SLEEP APNOEA SYNDROME 123 0.0843
30 VARICES OESOPHAGEAL 255 0.0842
31 BUNDLE BRANCH BLOCK LEFT 345 0.0813
32 NEPHROGENIC ANAEMIA 365 0.0787
33 DYSPNOEA AT REST 223 0.0769
34 HYPERVOLAEMIA 380 0.0768
35 HEPATIC NEOPLASM MALIGNANT 161 0.0760
36 MITRAL VALVE INCOMPETENCE 851 0.0751
37 RHINITIS ALLERGIC 334 0.0750
38 PULMONARY ARTERIAL HYPERTENSION 1086 0.0749
39 INFUSION SITE HAEMORRHAGE 245 0.0744
40 TRICUSPID VALVE INCOMPETENCE 591 0.0743
41 HYPERPARATHYROIDISM SECONDARY 184 0.0734
42 RALES 426 0.0733
43 LEFT VENTRICULAR FAILURE 250 0.0725
44 INFUSION SITE INFECTION 168 0.0722
45 AMMONIA INCREASED 368 0.0721
46 VENTRICULAR HYPOKINESIA 231 0.0719
47 LEFT VENTRICULAR DYSFUNCTION 472 0.0704
48 EJECTION FRACTION DECREASED 1091 0.0701
49 CARDIAC FAILURE 5584 0.0695
50 PULMONARY HYPERTENSION 1447 0.0694
51 ASCITES 2014 0.0684
52 BLOOD POTASSIUM INCREASED 1109 0.0682
53 HYPOVOLAEMIA 399 0.0681
54 SINUS NODE DYSFUNCTION 123 0.0671
55 DEVICE INFUSION ISSUE 163 0.0657
56 VENTRICULAR TACHYCARDIA 1080 0.0653
57 CARDIOMEGALY 753 0.0612
58 THERAPEUTIC AGENT TOXICITY 203 0.0608
59 CATHETER SITE ERYTHEMA 130 0.0607
60 ESSENTIAL HYPERTENSION 110 0.0600
61 PORTAL HYPERTENSION 185 0.0599
62 DIASTOLIC DYSFUNCTION 183 0.0592
63 INFUSION SITE PAIN 757 0.0587
64 LEFT VENTRICULAR HYPERTROPHY 249 0.0581
65 GLOMERULAR FILTRATION RATE DECREASED 714 0.0580
66 AORTIC VALVE INCOMPETENCE 247 0.0580
67 BLOOD UREA INCREASED 959 0.0572
68 HYPONATRAEMIA 3144 0.0558
69 ATRIOVENTRICULAR BLOCK COMPLETE 371 0.0554
70 BLOOD PRESSURE SYSTOLIC DECREASED 252 0.0553
71 INFUSION SITE ERYTHEMA 466 0.0552
72 OXYGEN CONSUMPTION INCREASED 132 0.0552
73 DILATATION VENTRICULAR 116 0.0551
74 HEPATIC CIRRHOSIS 1029 0.0547
75 HAEMOGLOBIN INCREASED 245 0.0537
76 ACUTE KIDNEY INJURY 8113 0.0530
77 ATRIAL FLUTTER 415 0.0520
78 HAEMORRHAGIC ANAEMIA 228 0.0518
79 ATRIOVENTRICULAR BLOCK FIRST DEGREE 222 0.0512
80 BLOOD POTASSIUM ABNORMAL 135 0.0506
81 RENAL FAILURE ACUTE 2114 0.0498
82 EXERCISE TOLERANCE DECREASED 285 0.0495
83 CREPITATIONS 147 0.0493
84 REBOUND ACID HYPERSECRETION 149 0.0492
85 CONCOMITANT DISEASE AGGRAVATED 301 0.0487
86 VENTRICULAR ARRHYTHMIA 177 0.0483
87 CATHETER SITE HAEMORRHAGE 121 0.0483
88 INFUSION SITE SWELLING 303 0.0481
89 BLOOD LOSS ANAEMIA 109 0.0481
90 CARDIOMYOPATHY 704 0.0476
91 DYSPNOEA EXERTIONAL 1788 0.0474
92 AORTIC STENOSIS 164 0.0470
93 CARDIOGENIC SHOCK 662 0.0461
94 HYPERURICAEMIA 189 0.0459
95 ORTHOSTATIC HYPOTENSION 798 0.0458
96 CARDIAC DYSFUNCTION 170 0.0456
97 VASCULAR DEVICE INFECTION 207 0.0456
98 INTERNATIONAL NORMALISED RATIO INCREASED 1280 0.0448
99 BREATH SOUNDS ABNORMAL 221 0.0448
100 ATRIOVENTRICULAR BLOCK 346 0.0447
101 FLUID RETENTION 2242 0.0440
102 PROTHROMBIN TIME PROLONGED 263 0.0439
103 CATHETER SITE PAIN 113 0.0435
104 ACUTE PULMONARY OEDEMA 241 0.0429
105 FLUID OVERLOAD 619 0.0425
106 BLOOD CHLORIDE DECREASED 109 0.0422
107 CARDIAC FAILURE CONGESTIVE 3379 0.0420
108 ELECTROLYTE IMBALANCE 486 0.0418
109 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 367 0.0415
110 OLIGURIA 257 0.0414
111 ELECTROCARDIOGRAM ABNORMAL 321 0.0409
112 INFUSION SITE PRURITUS 129 0.0408
113 INFUSION SITE REACTION 122 0.0408
114 HYPOVOLAEMIC SHOCK 193 0.0403
115 BUNDLE BRANCH BLOCK RIGHT 184 0.0400
116 CREATININE RENAL CLEARANCE DECREASED 160 0.0399
117 IRON DEFICIENCY ANAEMIA 367 0.0397
118 VENTRICULAR FIBRILLATION 441 0.0397
119 SUPRAVENTRICULAR EXTRASYSTOLES 134 0.0396
120 POLYURIA 322 0.0393
121 VENTRICULAR EXTRASYSTOLES 405 0.0390
122 SLEEP APNOEA SYNDROME 744 0.0389
123 ANGINA UNSTABLE 252 0.0387
124 BRADYCARDIA 2048 0.0386
125 CARDIAC MURMUR 334 0.0386
126 HYPOKALAEMIA 1770 0.0383
127 BLOOD CREATINE INCREASED 168 0.0379
128 BLOOD SODIUM DECREASED 701 0.0372
129 URINE OUTPUT DECREASED 324 0.0370
130 BLOOD URIC ACID INCREASED 214 0.0370
131 GENERALISED OEDEMA 456 0.0368
132 PULMONARY CONGESTION 482 0.0365
133 BLOOD CREATININE INCREASED 2367 0.0362
134 CORONARY ARTERY STENOSIS 182 0.0362
135 MELAENA 796 0.0361
136 SINUS BRADYCARDIA 347 0.0359
137 HYPERCAPNIA 108 0.0358
138 OEDEMA PERIPHERAL 4370 0.0358
139 CATHETER SITE INFECTION 135 0.0357
140 CATHETERISATION CARDIAC 158 0.0356
141 AZOTAEMIA 142 0.0355
142 OEDEMA 1928 0.0355
143 HYPOTENSION 7037 0.0350
144 DIZZINESS POSTURAL 339 0.0349
145 RENAL FAILURE CHRONIC 268 0.0348
146 SHOCK HAEMORRHAGIC 281 0.0345
147 UPPER GASTROINTESTINAL HAEMORRHAGE 577 0.0343
148 RENAL IMPAIRMENT 2866 0.0341
149 INTERNATIONAL NORMALISED RATIO DECREASED 138 0.0340
150 PORTAL VEIN THROMBOSIS 110 0.0340
151 ATRIAL FIBRILLATION 3313 0.0340
152 BLOOD POTASSIUM DECREASED 1012 0.0336
153 HEPATIC FAILURE 1014 0.0336
154 LOCALISED OEDEMA 155 0.0335
155 CHRONIC KIDNEY DISEASE 2533 0.0333
156 HYPOALBUMINAEMIA 255 0.0328
157 PEMPHIGOID 247 0.0327
158 INTERNATIONAL NORMALISED RATIO ABNORMAL 112 0.0325
159 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 164 0.0324
160 PULMONARY OEDEMA 1450 0.0323
161 CARDIAC VALVE DISEASE 185 0.0323
162 END STAGE RENAL DISEASE 587 0.0322
163 ANURIA 274 0.0318
164 GASTRITIS EROSIVE 148 0.0317
165 TROPONIN INCREASED 240 0.0315
166 RED CELL DISTRIBUTION WIDTH INCREASED 131 0.0315
167 ACUTE RESPIRATORY FAILURE 601 0.0312
168 SEASONAL ALLERGY 439 0.0310
169 LOWER GASTROINTESTINAL HAEMORRHAGE 228 0.0308
170 PERICARDIAL EFFUSION 711 0.0307
171 CARPAL TUNNEL SYNDROME 429 0.0306
172 DERMATITIS CONTACT 345 0.0302
173 HEPATOMEGALY 296 0.0301
174 BLOOD PRESSURE DECREASED 2000 0.0301
175 BLOOD PRESSURE DIASTOLIC DECREASED 222 0.0300
176 CAROTID ARTERY STENOSIS 105 0.0300
177 BLOOD ALBUMIN DECREASED 238 0.0300
178 CAROTID ARTERY OCCLUSION 109 0.0298
179 RENAL FAILURE 3962 0.0298
180 EMBOLIC STROKE 105 0.0298
181 GOUT 534 0.0297
182 HYPOMAGNESAEMIA 413 0.0296
183 ARTERIOSCLEROSIS CORONARY ARTERY 195 0.0294
184 HYPERLIPIDAEMIA 351 0.0293
185 PLEURAL EFFUSION 1786 0.0293
186 HYPERNATRAEMIA 146 0.0293
187 MYOCARDIAL ISCHAEMIA 332 0.0291
188 DRUG INTERACTION 4622 0.0291
189 HAEMORRHOIDAL HAEMORRHAGE 142 0.0291
190 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 297 0.0289
191 DIABETIC NEUROPATHY 141 0.0285
192 BENIGN PROSTATIC HYPERPLASIA 147 0.0284
193 PROTEIN TOTAL DECREASED 107 0.0284
194 SUBARACHNOID HAEMORRHAGE 289 0.0283
195 PAIN IN JAW 803 0.0283
196 BLOOD TEST ABNORMAL 396 0.0282
197 DEHYDRATION 3758 0.0281
198 HEPATOCELLULAR CARCINOMA 214 0.0281
199 ACIDOSIS 214 0.0280
200 ERYSIPELAS 140 0.0278
201 TRANSFUSION 291 0.0277
202 WEIGHT FLUCTUATION 290 0.0277
203 UPPER-AIRWAY COUGH SYNDROME 228 0.0276
204 TORSADE DE POINTES 217 0.0276
205 BLOOD BILIRUBIN INCREASED 738 0.0273
206 SUBDURAL HAEMATOMA 391 0.0273
207 PRODUCT ADMINISTRATION INTERRUPTED 213 0.0271
208 OXYGEN SATURATION DECREASED 1517 0.0270
209 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 138 0.0269
210 ENDOCARDITIS 138 0.0269
211 RENAL CYST 211 0.0265
212 MULTIPLE ALLERGIES 208 0.0265
213 ATELECTASIS 256 0.0265
214 BLOOD PRESSURE INADEQUATELY CONTROLLED 159 0.0264
215 DYSLIPIDAEMIA 134 0.0264
216 PURPURA 233 0.0263
217 DIVERTICULUM INTESTINAL 115 0.0263
218 PURULENT DISCHARGE 112 0.0262
219 BLOOD MAGNESIUM DECREASED 223 0.0258
220 CARDIAC PACEMAKER INSERTION 154 0.0258
221 HAEMATOMA 668 0.0258
222 GASTROINTESTINAL HAEMORRHAGE 2154 0.0257
223 HAEMOPTYSIS 718 0.0257
224 METABOLIC ACIDOSIS 822 0.0257
225 SPLENOMEGALY 301 0.0257
226 ARRHYTHMIA 1216 0.0257
227 OBSTRUCTIVE AIRWAYS DISORDER 285 0.0256
228 HYPOTHYROIDISM 803 0.0251
229 STAPHYLOCOCCAL SEPSIS 124 0.0251
230 DUODENAL ULCER 177 0.0251
231 TENSION HEADACHE 107 0.0249
232 HYPERTHYROIDISM 360 0.0248
233 LACTIC ACIDOSIS 802 0.0247
234 ACUTE MYOCARDIAL INFARCTION 726 0.0246
235 COAGULOPATHY 406 0.0243
236 SUDDEN DEATH 257 0.0243
237 IRON DEFICIENCY 109 0.0242
238 ARTERIOSCLEROSIS 228 0.0242
239 EPISTAXIS 1809 0.0242
240 CIRCULATORY COLLAPSE 411 0.0241
241 SKIN ABRASION 114 0.0241
242 RENAL FUNCTION TEST ABNORMAL 112 0.0241
243 HYPOXIA 844 0.0239
244 ANGINA PECTORIS 686 0.0239
245 SYNCOPE 2392 0.0239
246 PRE-EXISTING CONDITION IMPROVED 149 0.0238
247 FULL BLOOD COUNT ABNORMAL 252 0.0238
248 EOSINOPHILIA 416 0.0237
249 PERIPHERAL VASCULAR DISORDER 122 0.0237
250 HEART RATE ABNORMAL 132 0.0236
251 MULTIPLE INJURIES 149 0.0236
252 NEPHROPATHY 220 0.0235
253 CORONARY ARTERY DISEASE 712 0.0235
254 HAEMODYNAMIC INSTABILITY 179 0.0235
255 RENAL TUBULAR NECROSIS 230 0.0234
256 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1213 0.0232
257 SUPRAVENTRICULAR TACHYCARDIA 222 0.0232
258 HYPERBILIRUBINAEMIA 240 0.0231
259 HYPOCALCAEMIA 436 0.0230
260 HIDRADENITIS 210 0.0230
261 GLUCOSE TOLERANCE IMPAIRED 136 0.0230
262 VARICOSE VEIN 118 0.0228
263 FEMORAL NECK FRACTURE 117 0.0228
264 TOXIC EPIDERMAL NECROLYSIS 346 0.0228
265 PRESYNCOPE 550 0.0226
266 MALNUTRITION 253 0.0226
267 HAEMATEMESIS 572 0.0225
268 ANAEMIA 4260 0.0223
269 ECONOMIC PROBLEM 338 0.0223
270 TACHYPNOEA 303 0.0223
271 CORONARY ARTERY OCCLUSION 304 0.0221
272 RENAL DISORDER 1029 0.0221
273 UROSEPSIS 203 0.0220
274 HEART RATE DECREASED 770 0.0219
275 PRODUCTIVE COUGH 1046 0.0219
276 EOSINOPHIL COUNT INCREASED 182 0.0218
277 GAMMA-GLUTAMYLTRANSFERASE INCREASED 483 0.0218
278 HYPOPHOSPHATAEMIA 161 0.0218
279 HEART RATE IRREGULAR 492 0.0218
280 ECCHYMOSIS 149 0.0217
281 MULTI-ORGAN FAILURE 374 0.0216
282 DYSPNOEA 12233 0.0216
283 JAUNDICE 577 0.0214
284 BLOOD ALKALINE PHOSPHATASE INCREASED 530 0.0213
285 DEVICE RELATED INFECTION 328 0.0213
286 CELLULITIS 1067 0.0212
287 ENCEPHALOPATHY 517 0.0210
288 HAEMATOCRIT DECREASED 417 0.0210
289 ISCHAEMIC STROKE 374 0.0209
290 AGRANULOCYTOSIS 389 0.0209
291 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 355 0.0209
292 LYMPHOEDEMA 144 0.0208
293 HYPOGLYCAEMIA 1004 0.0207
294 DIVERTICULUM 147 0.0207
295 GENERAL PHYSICAL HEALTH DETERIORATION 2393 0.0207
296 BLOOD PRESSURE ABNORMAL 411 0.0207
297 INFARCTION 141 0.0206
298 BLOOD LACTIC ACID INCREASED 107 0.0203
299 RESPIRATORY FAILURE 1468 0.0201
300 HEPATITIS CHOLESTATIC 121 0.0201
301 EXTRASYSTOLES 140 0.0200
302 GASTROENTERITIS 292 0.0200
303 RESPIRATORY SYNCYTIAL VIRUS INFECTION 174 0.0200
304 PRODUCT PRESCRIBING ERROR 476 0.0200
305 DECUBITUS ULCER 162 0.0199
306 HAEMATURIA 680 0.0198
307 CARDIAC FLUTTER 128 0.0198
308 INGUINAL HERNIA 120 0.0197
309 BREAST PAIN 210 0.0197
310 INTESTINAL ISCHAEMIA 108 0.0196
311 PERIPHERAL COLDNESS 269 0.0196
312 SEPTIC SHOCK 852 0.0196
313 RENAL INJURY 581 0.0195
314 INABILITY TO AFFORD MEDICATION 194 0.0195
315 RHABDOMYOLYSIS 814 0.0195
316 INTERNAL HAEMORRHAGE 223 0.0195
317 CARDIAC DISORDER 1804 0.0193
318 CLOSTRIDIUM DIFFICILE COLITIS 204 0.0192
319 LARGE INTESTINE POLYP 133 0.0192
320 SKIN ULCER 493 0.0191
321 TOXIC SKIN ERUPTION 191 0.0189
322 HYPOTONIA 189 0.0189
323 HAEMOGLOBIN DECREASED 1936 0.0188
324 HIATUS HERNIA 244 0.0188
325 LUNG INFILTRATION 166 0.0188
326 TUBULOINTERSTITIAL NEPHRITIS 352 0.0188
327 GASTRITIS 489 0.0186
328 GASTRIC ULCER 353 0.0186
329 CYANOSIS 291 0.0185
330 BREAST TENDERNESS 139 0.0184
331 MYOPATHY 159 0.0184
332 RESPIRATORY DISTRESS 508 0.0184
333 DERMATITIS BULLOUS 133 0.0184
334 GASTROOESOPHAGEAL REFLUX DISEASE 1479 0.0184
335 PULMONARY MASS 273 0.0183
336 CARDIAC ARREST 1511 0.0183
337 FIBROMYALGIA 444 0.0182
338 ACUTE CORONARY SYNDROME 151 0.0182
339 HAEMODIALYSIS 153 0.0182
340 HYPOPHAGIA 465 0.0182
341 NEPHROTIC SYNDROME 124 0.0181
342 URINARY RETENTION 603 0.0181
343 ABDOMINAL DISTENSION 1885 0.0180
344 BLOOD THYROID STIMULATING HORMONE INCREASED 166 0.0180
345 BACTERAEMIA 214 0.0180
346 BREAST MASS 121 0.0180
347 OBESITY 287 0.0180
348 SKIN LACERATION 195 0.0179
349 ELECTROCARDIOGRAM QT PROLONGED 644 0.0179
350 LIVER DISORDER 790 0.0178
351 PERIPHERAL SWELLING 2737 0.0177
352 SHOCK 408 0.0177
353 RESPIRATORY TRACT INFECTION 461 0.0177
354 HEPATIC FUNCTION ABNORMAL 659 0.0176
355 FACIAL PAIN 157 0.0176
356 BLOOD IRON DECREASED 208 0.0175
357 FALL 5800 0.0174
358 RASH MACULO-PAPULAR 387 0.0174
359 CARDIO-RESPIRATORY ARREST 727 0.0174
360 ALTERED STATE OF CONSCIOUSNESS 376 0.0173
361 RECTAL HAEMORRHAGE 745 0.0173
362 DIABETES MELLITUS INADEQUATE CONTROL 306 0.0173
363 POOR QUALITY SLEEP 372 0.0173
364 EMPHYSEMA 174 0.0172
365 MULTIPLE ORGAN DYSFUNCTION SYNDROME 488 0.0172
366 AORTIC ANEURYSM 131 0.0172
367 CHEST PAIN 3177 0.0171
368 HYPERGLYCAEMIA 622 0.0171
369 GYNAECOMASTIA 528 0.0170
370 COUGH 4780 0.0170
371 VITAMIN D DEFICIENCY 166 0.0170
372 BLOOD PRESSURE FLUCTUATION 407 0.0169
373 SEPSIS 1880 0.0168
374 HAEMORRHOIDS 327 0.0167
375 NOCTURIA 203 0.0167
376 ASPARTATE AMINOTRANSFERASE INCREASED 885 0.0166
377 HEAD INJURY 524 0.0165
378 RESPIRATORY RATE INCREASED 147 0.0165
379 FLANK PAIN 155 0.0165
380 PROTEINURIA 314 0.0165
381 DECREASED ACTIVITY 178 0.0165
382 VASCULITIS 192 0.0165
383 DEVICE OCCLUSION 231 0.0164
384 ASPHYXIA 134 0.0164
385 CHOLECYSTITIS 195 0.0164
386 SPINAL OSTEOARTHRITIS 143 0.0163
387 PALPITATIONS 1903 0.0162
388 INSURANCE ISSUE 248 0.0162
389 LIVER FUNCTION TEST ABNORMAL 471 0.0162
390 BLOOD PRESSURE SYSTOLIC INCREASED 314 0.0161
391 FAECES DISCOLOURED 349 0.0161
392 CEREBRAL INFARCTION 392 0.0160
393 PNEUMONIA ASPIRATION 400 0.0160
394 CHOLESTASIS 307 0.0160
395 LIPASE INCREASED 122 0.0159
396 CONTRAINDICATED PRODUCT ADMINISTERED 482 0.0159
397 HYPOKINESIA 231 0.0159
398 ADRENAL INSUFFICIENCY 193 0.0159
399 HAEMORRHAGIC STROKE 124 0.0159
400 SINUS TACHYCARDIA 223 0.0157
401 MENTAL STATUS CHANGES 436 0.0157
402 RIB FRACTURE 321 0.0156
403 SPUTUM DISCOLOURED 148 0.0156
404 CHOLELITHIASIS 511 0.0156
405 WHEEZING 922 0.0155
406 ASPIRATION 170 0.0155
407 POST PROCEDURAL HAEMORRHAGE 180 0.0154
408 DISSEMINATED INTRAVASCULAR COAGULATION 217 0.0154
409 PNEUMONIA 4985 0.0154
410 RESPIRATION ABNORMAL 106 0.0154
411 CONFUSIONAL STATE 2484 0.0154
412 IMPAIRED GASTRIC EMPTYING 209 0.0153
413 ASTHENIA 5754 0.0153
414 BRONCHITIS 1132 0.0153
415 MOUTH HAEMORRHAGE 112 0.0153
416 DECREASED APPETITE 3545 0.0152
417 C-REACTIVE PROTEIN INCREASED 552 0.0152
418 URINARY TRACT INFECTION 2587 0.0152
419 DRUG LEVEL INCREASED 251 0.0151
420 WEIGHT DECREASED 4190 0.0150
421 TYPE 2 DIABETES MELLITUS 505 0.0150
422 PETECHIAE 156 0.0149
423 PSEUDOMONAS INFECTION 128 0.0149
424 PALLOR 406 0.0149
425 INCREASED TENDENCY TO BRUISE 137 0.0149
426 THIRST 265 0.0148
427 PNEUMONIA BACTERIAL 136 0.0148
428 HEPATOCELLULAR INJURY 210 0.0148
429 ORAL CANDIDIASIS 195 0.0148
430 PLATELET COUNT DECREASED 1577 0.0148
431 DIZZINESS 7364 0.0147
432 HEPATIC STEATOSIS 275 0.0147
433 COVID-19 PNEUMONIA 174 0.0147
434 HEART RATE INCREASED 1453 0.0147
435 WEIGHT INCREASED 3283 0.0146
436 APNOEA 114 0.0146
437 PULMONARY HAEMORRHAGE 114 0.0146
438 INTERSTITIAL LUNG DISEASE 705 0.0145
439 RED BLOOD CELL COUNT DECREASED 416 0.0145
440 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 113 0.0145
441 HYPERTENSION 3075 0.0145
442 BLOOD CALCIUM DECREASED 163 0.0145
443 LEUKOCYTOSIS 262 0.0145
444 OESOPHAGITIS 158 0.0144
445 NASAL CONGESTION 848 0.0144
446 LETHARGY 830 0.0144
447 TACHYCARDIA 1280 0.0144
448 INCONTINENCE 152 0.0144
449 ARTERIAL OCCLUSIVE DISEASE 113 0.0144
450 POLLAKIURIA 599 0.0143
451 DYSURIA 528 0.0143
452 ANAL INCONTINENCE 129 0.0143
453 MYOCLONUS 171 0.0143
454 LUNG DISORDER 702 0.0143
455 MUSCULOSKELETAL CHEST PAIN 221 0.0143
456 CHEST DISCOMFORT 1457 0.0142
457 HYPOTHERMIA 144 0.0142
458 ALANINE AMINOTRANSFERASE INCREASED 870 0.0142
459 DISORIENTATION 559 0.0141
460 PRESCRIBED UNDERDOSE 281 0.0141
461 CONTUSION 1352 0.0140
462 BODY TEMPERATURE DECREASED 138 0.0140
463 LOSS OF CONSCIOUSNESS 1792 0.0140
464 MYOCARDITIS 160 0.0139
465 THERAPY NON-RESPONDER 625 0.0139
466 HEPATITIS C 167 0.0138
467 HEMIPLEGIA 115 0.0138
468 STEVENS-JOHNSON SYNDROME 304 0.0137
469 WHITE BLOOD CELL COUNT INCREASED 523 0.0136
470 CARDIAC OPERATION 117 0.0136
471 HYPERCALCAEMIA 168 0.0136
472 DIVERTICULITIS 377 0.0136
473 ANOREXIA 175 0.0136
474 DELIRIUM 471 0.0136
475 RETCHING 288 0.0135
476 DRY THROAT 137 0.0135
477 SINUS CONGESTION 182 0.0135
478 DEPRESSED LEVEL OF CONSCIOUSNESS 532 0.0134
479 PANCREATITIS ACUTE 302 0.0134
480 CHOKING 262 0.0134
481 LIMB INJURY 363 0.0134
482 DIARRHOEA 8623 0.0133
483 RESPIRATORY TRACT CONGESTION 212 0.0133
484 BRAIN FOG 209 0.0133
485 CONDITION AGGRAVATED 4048 0.0133
486 GASTRIC HAEMORRHAGE 153 0.0133
487 GLYCOSYLATED HAEMOGLOBIN INCREASED 335 0.0133
488 HOSPICE CARE 131 0.0132
489 STAPHYLOCOCCAL INFECTION 437 0.0132
490 PARKINSONISM 129 0.0132
491 TRANSIENT ISCHAEMIC ATTACK 446 0.0132
492 SPINAL COMPRESSION FRACTURE 109 0.0132
493 MUSCLE ATROPHY 167 0.0132
494 GALLBLADDER DISORDER 235 0.0132
495 BLOOD COUNT ABNORMAL 199 0.0131
496 CLOSTRIDIUM DIFFICILE INFECTION 286 0.0131
497 SWELLING 1225 0.0131
498 IMPAIRED QUALITY OF LIFE 188 0.0131
499 PYELONEPHRITIS 113 0.0130
500 GINGIVAL BLEEDING 178 0.0130
501 URINARY INCONTINENCE 386 0.0130
502 WRIST FRACTURE 156 0.0130
503 BODY HEIGHT DECREASED 139 0.0130
504 HAEMATOCHEZIA 717 0.0130
505 FEEDING DISORDER 263 0.0130
506 GASTROENTERITIS VIRAL 234 0.0129
507 PANCYTOPENIA 722 0.0129
508 LOCALISED INFECTION 311 0.0128
509 MOTOR DYSFUNCTION 131 0.0128
510 TREATMENT NONCOMPLIANCE 703 0.0128
511 MUSCULAR WEAKNESS 1458 0.0128
512 THROMBOCYTOPENIA 1433 0.0128
513 PERITONITIS BACTERIAL 129 0.0128
514 ESCHERICHIA INFECTION 105 0.0128
515 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 613 0.0127
516 DRUG ERUPTION 226 0.0127
517 UPPER RESPIRATORY TRACT INFECTION 586 0.0127
518 CEREBRAL HAEMORRHAGE 453 0.0126
519 DIABETES MELLITUS 964 0.0126
520 BLOOD PRESSURE INCREASED 1926 0.0126
521 HYPERTENSIVE CRISIS 140 0.0126
522 INITIAL INSOMNIA 129 0.0126
523 SLUGGISHNESS 128 0.0125
524 PNEUMOTHORAX 199 0.0125
525 ACUTE RESPIRATORY DISTRESS SYNDROME 221 0.0125
526 TENDERNESS 130 0.0125
527 INTENTIONAL DOSE OMISSION 354 0.0124
528 DIALYSIS 176 0.0124
529 ABDOMINAL PAIN 2884 0.0124
530 THROAT IRRITATION 556 0.0124
531 MUSCLE STRAIN 107 0.0124
532 CONSTIPATION 2686 0.0123
533 KIDNEY INFECTION 241 0.0123
534 MYOSITIS 110 0.0122
535 FATIGUE 9465 0.0121
536 VIRAL INFECTION 404 0.0121
537 HYPERCHOLESTEROLAEMIA 117 0.0121
538 RESTLESS LEGS SYNDROME 220 0.0121
539 FACE OEDEMA 204 0.0121
540 BLOOD CALCIUM INCREASED 106 0.0121
541 SCIATICA 192 0.0120
542 HEMIPARESIS 204 0.0120
543 PULMONARY FIBROSIS 231 0.0120
544 BLOOD CREATINE PHOSPHOKINASE INCREASED 346 0.0120
545 SINUS DISORDER 238 0.0120
546 TOOTH INFECTION 158 0.0120
547 UNRESPONSIVE TO STIMULI 309 0.0120
548 LIGAMENT SPRAIN 118 0.0119
549 PRODUCT ADMINISTRATION ERROR 241 0.0119
550 ROTATOR CUFF SYNDROME 153 0.0119
551 BLOOD GLUCOSE FLUCTUATION 130 0.0119
552 SMALL INTESTINAL OBSTRUCTION 146 0.0118
553 POLYNEUROPATHY 142 0.0118
554 MYOCARDIAL INFARCTION 2061 0.0118
555 NEURALGIA 287 0.0118
556 THERAPY PARTIAL RESPONDER 183 0.0117
557 DEEP VEIN THROMBOSIS 758 0.0117
558 BLOOD TRIGLYCERIDES INCREASED 206 0.0116
559 ABSCESS 186 0.0116
560 CYSTITIS 371 0.0116
561 DEMENTIA 325 0.0116
562 POST PROCEDURAL COMPLICATION 223 0.0116
563 VOMITING 5456 0.0116
564 LACERATION 109 0.0116
565 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 298 0.0116
566 HYPERSOMNIA 331 0.0115
567 MUSCLE TWITCHING 266 0.0115
568 CHROMATURIA 260 0.0115
569 RESPIRATORY DISORDER 344 0.0115
570 COLD SWEAT 202 0.0114
571 MUSCULOSKELETAL DISCOMFORT 197 0.0114
572 BACK PAIN 2656 0.0114
573 HALLUCINATION, VISUAL 241 0.0114
574 VERTIGO 695 0.0114
575 MIDDLE INSOMNIA 212 0.0113
576 MALAISE 4977 0.0113
577 RHINORRHOEA 733 0.0113
578 PHOTOSENSITIVITY REACTION 187 0.0113
579 OSTEOARTHRITIS 478 0.0113
580 ACUTE HEPATIC FAILURE 154 0.0113
581 MUSCLE SPASMS 2068 0.0113
582 FLATULENCE 639 0.0113
583 BACTERIAL INFECTION 210 0.0112
584 FLUSHING 1143 0.0112
585 TEMPERATURE INTOLERANCE 116 0.0112
586 ASTHMA 1270 0.0112
587 NAUSEA 8883 0.0112
588 THYROID DISORDER 173 0.0112
589 POOR VENOUS ACCESS 116 0.0112
590 BLOOD URINE PRESENT 211 0.0111
591 BLOOD LACTATE DEHYDROGENASE INCREASED 176 0.0111
592 DYSPHONIA 649 0.0111
593 OSTEOPOROSIS 456 0.0111
594 FEELING COLD 308 0.0111
595 PNEUMOCYSTIS JIROVECII PNEUMONIA 111 0.0110
596 COMPLICATION ASSOCIATED WITH DEVICE 160 0.0110
597 SKIN DISORDER 367 0.0110
598 DRUG PRESCRIBING ERROR 211 0.0110
599 HEPATIC CYTOLYSIS 140 0.0110
600 BALANCE DISORDER 949 0.0110
601 FULL BLOOD COUNT DECREASED 221 0.0110
602 NECK PAIN 608 0.0109
603 PULMONARY EMBOLISM 1032 0.0108
604 ANHEDONIA 285 0.0108
605 CANDIDA INFECTION 183 0.0108
606 PAIN IN EXTREMITY 3192 0.0108
607 EAR DISCOMFORT 111 0.0108
608 HEADACHE 6779 0.0108
609 LYMPHOCYTE COUNT DECREASED 191 0.0108
610 HAEMORRHAGE INTRACRANIAL 161 0.0108
611 SARS-COV-2 TEST POSITIVE 142 0.0107
612 GAIT DISTURBANCE 2057 0.0107
613 DRUG-INDUCED LIVER INJURY 337 0.0107
614 OSTEOPENIA 163 0.0107
615 PULMONARY THROMBOSIS 117 0.0107
616 ABDOMINAL PAIN UPPER 2208 0.0107
617 JOINT INJURY 229 0.0107
618 HEPATITIS 274 0.0107
619 RENAL PAIN 113 0.0106
620 DYSPHAGIA 1011 0.0106
621 DYSARTHRIA 399 0.0106
622 JOINT DISLOCATION 112 0.0106
623 SKIN HAEMORRHAGE 157 0.0106
624 WOUND INFECTION 116 0.0106
625 OROPHARYNGEAL PAIN 979 0.0106
626 DYSPEPSIA 1037 0.0105
627 PARAESTHESIA ORAL 152 0.0105
628 SKIN INFECTION 118 0.0105
629 SKIN LESION 288 0.0105
630 DISEASE PROGRESSION 1241 0.0105
631 ANKLE FRACTURE 162 0.0105
632 SINUSITIS 1072 0.0104
633 PARALYSIS 149 0.0104
634 COLON CANCER 155 0.0104
635 ILEUS 129 0.0104
636 LABORATORY TEST ABNORMAL 306 0.0104
637 MYALGIA 1760 0.0103
638 MUSCULOSKELETAL PAIN 542 0.0103
639 ORAL PAIN 231 0.0103
640 BRONCHOSPASM 147 0.0103
641 CATARACT 611 0.0102
642 SPINAL PAIN 120 0.0102
643 SCRATCH 108 0.0102
644 HAEMORRHAGE 1070 0.0102
645 LUNG INFECTION 159 0.0102
646 BURNING SENSATION 716 0.0102
647 HAIR COLOUR CHANGES 127 0.0102
648 TASTE DISORDER 207 0.0102
649 INFLUENZA 1137 0.0102
650 HEAD DISCOMFORT 180 0.0102
651 CYST 126 0.0101
652 EATING DISORDER 216 0.0101
653 SOMNOLENCE 2038 0.0101
654 TRANSAMINASES INCREASED 225 0.0101
655 TOOTHACHE 183 0.0101
656 UNEVALUABLE EVENT 764 0.0101
657 SKIN DISCOLOURATION 464 0.0101
658 EYE INFECTION 114 0.0101
659 WOUND 282 0.0101
660 MICTURITION URGENCY 115 0.0101
661 INFLAMMATION 519 0.0100
662 ILLNESS 1031 0.0100
663 DYSSTASIA 292 0.0100
664 APHASIA 302 0.0100
665 BODY TEMPERATURE INCREASED 204 0.0100
666 SCAR 171 0.0100
667 DRY MOUTH 810 0.0100
668 INTERVERTEBRAL DISC PROTRUSION 218 0.0100
669 BLOOD GLUCOSE DECREASED 478 0.0099
670 OSTEOMYELITIS 180 0.0099
671 TINNITUS 455 0.0099
672 MUSCLE TIGHTNESS 160 0.0099
673 HIP FRACTURE 316 0.0098
674 GASTROINTESTINAL PAIN 108 0.0098
675 PYREXIA 3385 0.0098
676 ABDOMINAL DISCOMFORT 1640 0.0098
677 LIMB DISCOMFORT 302 0.0098
678 SPEECH DISORDER 511 0.0097
679 PLATELET COUNT INCREASED 127 0.0097
680 NEPHROPATHY TOXIC 109 0.0097
681 FEAR 260 0.0097
682 BACK DISORDER 157 0.0096
683 DEVICE FAILURE 147 0.0096
684 HERNIA 186 0.0096
685 FEELING ABNORMAL 2303 0.0096
686 ANGIOEDEMA 424 0.0096
687 ULCER 152 0.0095
688 DISTURBANCE IN ATTENTION 515 0.0095
689 DIPLOPIA 248 0.0095
690 LIP SWELLING 316 0.0095
691 FUNGAL INFECTION 316 0.0095
692 THROMBOSIS 761 0.0094
693 MUSCLE RIGIDITY 113 0.0094
694 INSOMNIA 2516 0.0094
695 NEPHROLITHIASIS 433 0.0094
696 GAIT INABILITY 314 0.0094
697 SPINAL FRACTURE 188 0.0094
698 SCAB 107 0.0094
699 SNEEZING 210 0.0094
700 BASAL CELL CARCINOMA 146 0.0093
701 MEMORY IMPAIRMENT 1285 0.0093
702 PANCREATITIS 494 0.0093
703 COVID-19 1633 0.0093
704 PHARYNGITIS 115 0.0093
705 LYMPHADENOPATHY 328 0.0093
706 SECRETION DISCHARGE 116 0.0093
707 BLOOD GLUCOSE INCREASED 1742 0.0092
708 AMNESIA 601 0.0092
709 COLITIS 350 0.0092
710 HYPERHIDROSIS 1189 0.0092
711 BLISTER 518 0.0092
712 EYE HAEMORRHAGE 123 0.0092
713 SLEEP DISORDER 650 0.0092
714 COGNITIVE DISORDER 429 0.0092
715 INFECTION 1325 0.0091
716 ERUCTATION 177 0.0091
717 DEVICE DISLOCATION 396 0.0091
718 TREMOR 1511 0.0091
719 QUALITY OF LIFE DECREASED 122 0.0091
720 HALLUCINATION 684 0.0091
721 PROSTATIC SPECIFIC ANTIGEN INCREASED 125 0.0091
722 ABDOMINAL PAIN LOWER 229 0.0090
723 EAR PAIN 176 0.0090
724 ARTHRITIS 712 0.0090
725 UPPER LIMB FRACTURE 180 0.0090
726 MOBILITY DECREASED 649 0.0090
727 FOOT FRACTURE 171 0.0090
728 ORAL HERPES 176 0.0090
729 NEUROPATHY PERIPHERAL 856 0.0090
730 LOWER RESPIRATORY TRACT INFECTION 409 0.0090
731 PERICARDITIS 151 0.0090
732 LIVER FUNCTION TEST INCREASED 192 0.0089
733 IMPAIRED HEALING 293 0.0089
734 ANOSMIA 129 0.0089
735 DERMATITIS ALLERGIC 112 0.0089
736 DRUG INTOLERANCE 860 0.0089
737 THERAPY INTERRUPTED 636 0.0089
738 CHILLS 1041 0.0089
739 HYPOACUSIS 381 0.0088
740 NASOPHARYNGITIS 1629 0.0088
741 PRURITUS GENERALISED 191 0.0088
742 ARTHRALGIA 3669 0.0088
743 HERPES ZOSTER 507 0.0088
744 RASH MACULAR 308 0.0088
745 PRURITUS 3365 0.0087
746 BEDRIDDEN 115 0.0087
747 APHONIA 122 0.0087
748 AGEUSIA 218 0.0087
749 ANXIETY 2484 0.0087
750 APATHY 127 0.0087
751 CARDIOVASCULAR DISORDER 221 0.0087
752 DEAFNESS 227 0.0087
753 SKIN FISSURES 169 0.0086
754 HOT FLUSH 651 0.0086
755 TOOTH DISORDER 192 0.0086
756 HYPOAESTHESIA 1291 0.0086
757 FEELING HOT 528 0.0086
758 RASH PAPULAR 193 0.0086
759 JOINT SWELLING 1039 0.0086
760 METASTASES TO LIVER 151 0.0086
761 NODULE 112 0.0086
762 INTENTIONAL PRODUCT USE ISSUE 751 0.0086
763 HOSPITALISATION 1317 0.0086
764 CONJUNCTIVITIS 158 0.0085
765 INJURY 598 0.0085
766 BONE PAIN 496 0.0085
767 DEPRESSION 1913 0.0084
768 GASTROINTESTINAL DISORDER 753 0.0084
769 RASH PRURITIC 455 0.0084
770 BLOOD CHOLESTEROL INCREASED 390 0.0084
771 RESTLESSNESS 306 0.0084
772 MIGRAINE 798 0.0084
773 CEREBROVASCULAR ACCIDENT 1413 0.0083
774 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 194 0.0083
775 ACTIVITIES OF DAILY LIVING IMPAIRED 164 0.0083
776 SWELLING FACE 539 0.0083
777 NERVOUSNESS 432 0.0083
778 RESPIRATORY ARREST 227 0.0082
779 MYELODYSPLASTIC SYNDROME 119 0.0082
780 INTESTINAL OBSTRUCTION 309 0.0082
781 PNEUMONITIS 223 0.0082
782 COMA 390 0.0082
783 FRACTURE 155 0.0082
784 LEUKOPENIA 409 0.0082
785 BLOOD GLUCOSE ABNORMAL 151 0.0082
786 IMMUNODEFICIENCY 121 0.0081
787 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 577 0.0081
788 SWOLLEN TONGUE 253 0.0081
789 AGITATION 594 0.0081
790 EYE PAIN 456 0.0081
791 MEDICATION ERROR 449 0.0081
792 NEUTROPHIL COUNT DECREASED 329 0.0081
793 BONE DISORDER 147 0.0081
794 METASTASES TO BONE 132 0.0080
795 PAIN 4916 0.0080
796 WHITE BLOOD CELL COUNT DECREASED 866 0.0080
797 PANIC ATTACK 291 0.0080
798 FREQUENT BOWEL MOVEMENTS 215 0.0080
799 SKIN CANCER 171 0.0079
800 HEPATIC ENZYME INCREASED 541 0.0079
801 PAIN OF SKIN 213 0.0079
802 VISUAL IMPAIRMENT 979 0.0079
803 FEMUR FRACTURE 244 0.0079
804 VISION BLURRED 1075 0.0078
805 PRODUCT AVAILABILITY ISSUE 178 0.0078
806 DEPRESSED MOOD 413 0.0078
807 IRRITABLE BOWEL SYNDROME 167 0.0078
808 BLINDNESS 317 0.0078
809 RASH ERYTHEMATOUS 371 0.0078
810 TENDONITIS 120 0.0077
811 STOMATITIS 469 0.0077
812 LACRIMATION INCREASED 232 0.0077
813 SURGERY 448 0.0076
814 MOUTH ULCERATION 161 0.0076
815 IMPAIRED WORK ABILITY 163 0.0076
816 FEELING JITTERY 145 0.0076
817 DERMATITIS 159 0.0076
818 DISEASE RECURRENCE 359 0.0075
819 ALOPECIA 1482 0.0075
820 NIGHT SWEATS 243 0.0075
821 THERAPEUTIC RESPONSE UNEXPECTED 338 0.0075
822 OFF LABEL USE 6594 0.0075
823 DISCOMFORT 457 0.0075
824 PRODUCT DOSE OMISSION IN ERROR 212 0.0075
825 MUCOSAL INFLAMMATION 196 0.0075
826 PERITONITIS 155 0.0075
827 LIVER INJURY 183 0.0074
828 SEROTONIN SYNDROME 143 0.0074
829 HEPATOTOXICITY 164 0.0074
830 PRODUCT USE ISSUE 1382 0.0073
831 PRODUCT DOSE OMISSION ISSUE 2159 0.0073
832 LOWER LIMB FRACTURE 141 0.0073
833 ECZEMA 384 0.0073
834 LOCAL SWELLING 128 0.0073
835 PHOTOPHOBIA 138 0.0073
836 EYE PRURITUS 246 0.0073
837 DRY EYE 364 0.0073
838 DYSGEUSIA 540 0.0073
839 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1308 0.0073
840 ABASIA 179 0.0072
841 EYE SWELLING 269 0.0072
842 GASTRIC DISORDER 248 0.0072
843 NIGHTMARE 250 0.0072
844 GLAUCOMA 139 0.0072
845 ROAD TRAFFIC ACCIDENT 299 0.0071
846 EAR INFECTION 190 0.0071
847 RASH 3103 0.0071
848 MANIA 117 0.0071
849 MOVEMENT DISORDER 228 0.0071
850 ERECTILE DYSFUNCTION 182 0.0071
851 MENTAL DISORDER 308 0.0071
852 DRY SKIN 932 0.0070
853 PARAESTHESIA 1092 0.0069
854 FEBRILE NEUTROPENIA 460 0.0069
855 CRYING 252 0.0069
856 PRODUCT USE COMPLAINT 109 0.0069
857 ACCIDENTAL OVERDOSE 253 0.0069
858 THERAPY CESSATION 355 0.0069
859 ERYTHEMA 1418 0.0069
860 DIABETIC KETOACIDOSIS 165 0.0069
861 SKIN EXFOLIATION 579 0.0069
862 VAGINAL HAEMORRHAGE 297 0.0068
863 PROCEDURAL PAIN 186 0.0067
864 DYSKINESIA 272 0.0067
865 SEIZURE 771 0.0067
866 PRODUCT USE IN UNAPPROVED INDICATION 1643 0.0066
867 PRESCRIBED OVERDOSE 128 0.0066
868 MENTAL IMPAIRMENT 160 0.0066
869 NEUTROPENIA 891 0.0065
870 INCREASED APPETITE 125 0.0065
871 TOXICITY TO VARIOUS AGENTS 1093 0.0065
872 GLOSSODYNIA 145 0.0065
873 THROAT TIGHTNESS 175 0.0065
874 DRUG RESISTANCE 166 0.0065
875 KNEE ARTHROPLASTY 136 0.0065
876 MULTIPLE FRACTURES 106 0.0064
877 SEDATION 168 0.0064
878 PRODUCT SUBSTITUTION ISSUE 369 0.0064
879 BONE MARROW FAILURE 130 0.0064
880 MUSCULOSKELETAL STIFFNESS 560 0.0064
881 INFLUENZA LIKE ILLNESS 526 0.0064
882 EYE DISORDER 210 0.0064
883 DEATH 5496 0.0064
884 PELVIC PAIN 115 0.0063
885 THINKING ABNORMAL 116 0.0062
886 NEOPLASM PROGRESSION 216 0.0062
887 ANAPHYLACTIC SHOCK 160 0.0062
888 PLASMA CELL MYELOMA 242 0.0062
889 RASH GENERALISED 160 0.0062
890 UNDERDOSE 450 0.0062
891 JOINT STIFFNESS 159 0.0061
892 PRODUCT DOSE OMISSION 395 0.0060
893 VISUAL ACUITY REDUCED 200 0.0060
894 ARTHROPATHY 333 0.0060
895 MALIGNANT NEOPLASM PROGRESSION 612 0.0060
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
897 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 423 0.0059
898 EMOTIONAL DISORDER 182 0.0059
899 PRODUCT DISPENSING ERROR 128 0.0059
900 PRODUCT PRESCRIBING ISSUE 127 0.0058
901 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1181 0.0058
902 INTENTIONAL PRODUCT MISUSE 509 0.0058
903 INFUSION RELATED REACTION 385 0.0058
904 HYPERSENSITIVITY 1070 0.0058
905 IRRITABILITY 342 0.0057
906 ILL-DEFINED DISORDER 341 0.0056
907 DEVICE MALFUNCTION 393 0.0056
908 OCULAR HYPERAEMIA 261 0.0055
909 LUNG NEOPLASM MALIGNANT 225 0.0055
910 CYTOKINE RELEASE SYNDROME 109 0.0054
911 URTICARIA 905 0.0054
912 DISABILITY 105 0.0053
913 SYSTEMIC LUPUS ERYTHEMATOSUS 188 0.0053
914 BONE DENSITY DECREASED 165 0.0053
915 ANAPHYLACTIC REACTION 288 0.0052
916 DEVICE LEAKAGE 226 0.0052
917 ANGER 175 0.0052
918 DRUG ADMINISTRATION ERROR 158 0.0051
919 EPILEPSY 154 0.0050
920 NERVOUS SYSTEM DISORDER 157 0.0050
921 CONVULSION 285 0.0050
922 ABNORMAL BEHAVIOUR 197 0.0050
923 ADVERSE EVENT 454 0.0049
924 ABNORMAL DREAMS 136 0.0049
925 EYE IRRITATION 283 0.0049
926 MOOD SWINGS 156 0.0049
927 MOOD ALTERED 132 0.0048
928 DEVICE ISSUE 432 0.0048
929 AGGRESSION 237 0.0047
930 ADVERSE DRUG REACTION 421 0.0047
931 INJECTION SITE RASH 143 0.0047
932 EMOTIONAL DISTRESS 563 0.0046
933 PSYCHOTIC DISORDER 136 0.0046
934 THERAPEUTIC RESPONSE DECREASED 277 0.0046
935 DRUG INEFFECTIVE 6015 0.0046
936 RHEUMATOID ARTHRITIS 512 0.0045
937 SUICIDAL IDEATION 405 0.0044
938 HEPATIC CANCER 106 0.0044
939 PSORIASIS 575 0.0044
940 INCORRECT DOSE ADMINISTERED 999 0.0044
941 NEOPLASM MALIGNANT 292 0.0044
942 INJECTION SITE PRURITUS 293 0.0044
943 OSTEONECROSIS OF JAW 107 0.0043
944 PHARMACEUTICAL PRODUCT COMPLAINT 112 0.0043
945 OVERDOSE 928 0.0043
946 ACNE 323 0.0043
947 DRUG DOSE OMISSION 699 0.0042
948 SUICIDE ATTEMPT 256 0.0042
949 DEVICE BREAKAGE 171 0.0042
950 THERAPEUTIC RESPONSE SHORTENED 139 0.0042
951 PSORIATIC ARTHROPATHY 169 0.0042
952 MENSTRUATION IRREGULAR 110 0.0041
953 INJECTION SITE BRUISING 327 0.0041
954 THERAPEUTIC PRODUCT EFFECT DECREASED 183 0.0041
955 EXTRA DOSE ADMINISTERED 163 0.0040
956 DEVICE USE ERROR 139 0.0040
957 WRONG TECHNIQUE IN DRUG USAGE PROCESS 145 0.0040
958 PANCREATIC CARCINOMA 115 0.0040
959 NEEDLE ISSUE 112 0.0038
960 DRUG EFFECT INCOMPLETE 139 0.0038
961 PREMATURE BABY 115 0.0038
962 DERMATITIS ATOPIC 201 0.0038
963 INJECTION SITE HAEMORRHAGE 296 0.0037
964 OSTEONECROSIS 121 0.0037
965 EXPIRED PRODUCT ADMINISTERED 122 0.0037
966 COLITIS ULCERATIVE 164 0.0037
967 INJECTION SITE MASS 135 0.0036
968 SKIN IRRITATION 165 0.0036
969 TREATMENT FAILURE 293 0.0035
970 INJECTION SITE ERYTHEMA 436 0.0035
971 WITHDRAWAL SYNDROME 143 0.0034
972 INJECTION SITE PAIN 1022 0.0033
973 PRODUCT QUALITY ISSUE 440 0.0032
974 INJECTION SITE SWELLING 246 0.0032
975 MATERNAL EXPOSURE DURING PREGNANCY 282 0.0032
976 DRUG EFFECT DECREASED 167 0.0031
977 INTENTIONAL OVERDOSE 192 0.0030
978 EXPOSURE DURING PREGNANCY 179 0.0029
979 COMPLETED SUICIDE 225 0.0027
980 NO ADVERSE EVENT 483 0.0027
981 INJECTION SITE REACTION 183 0.0027
982 FOETAL EXPOSURE DURING PREGNANCY 216 0.0027
983 MULTIPLE SCLEROSIS 127 0.0027
984 BREAST CANCER 240 0.0026
985 SKIN BURNING SENSATION 183 0.0026
986 MULTIPLE SCLEROSIS RELAPSE 150 0.0022
987 DEVICE DIFFICULT TO USE 137 0.0021
988 ACCIDENTAL EXPOSURE TO PRODUCT 206 0.0020
989 PROSTATE CANCER 153 0.0019
990 DEVICE EXPULSION 111 0.0017
991 DRUG ABUSE 135 0.0016
992 DRUG WITHDRAWAL SYNDROME 133 0.0015
993 PRODUCT STORAGE ERROR 118 0.0013
994 DRUG DEPENDENCE 180 0.0011